224 related articles for article (PubMed ID: 12838278)
21. Unrelated cord blood transplantation: outcomes after single-unit intrabone injection compared with double-unit intravenous injection in patients with hematological malignancies.
Rocha V; Labopin M; Ruggeri A; Podestà M; Gallamini A; Bonifazi F; Sanchez-Guijo FM; Rovira M; Socie G; Baltadakis I; Michallet M; Deconinck E; Bacigalupo A; Mohty M; Gluckman E; Frassoni F
Transplantation; 2013 May; 95(10):1284-91. PubMed ID: 23507699
[TBL] [Abstract][Full Text] [Related]
22. Umbilical cord blood transplantation--how, when and for whom?
Cohen Y; Nagler A
Blood Rev; 2004 Sep; 18(3):167-79. PubMed ID: 15183901
[TBL] [Abstract][Full Text] [Related]
23. Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation.
Rodrigues CA; Sanz G; Brunstein CG; Sanz J; Wagner JE; Renaud M; de Lima M; Cairo MS; Fürst S; Rio B; Dalley C; Carreras E; Harousseau JL; Mohty M; Taveira D; Dreger P; Sureda A; Gluckman E; Rocha V
J Clin Oncol; 2009 Jan; 27(2):256-63. PubMed ID: 19064984
[TBL] [Abstract][Full Text] [Related]
24. Unrelated cord blood and mismatched unrelated volunteer donor transplants, two alternatives in patients who lack an HLA-identical donor.
Ringdén O; Okas M; Uhlin M; Uzunel M; Remberger M; Mattsson J
Bone Marrow Transplant; 2008 Nov; 42(10):643-8. PubMed ID: 18762760
[TBL] [Abstract][Full Text] [Related]
25. Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival.
Gluckman E; Rocha V; Ionescu I; Bierings M; Harris RE; Wagner J; Kurtzberg J; Champagne MA; Bonfim C; Bittencourt M; Darbyshire P; Fernandez MN; Locatelli F; Pasquini R;
Biol Blood Marrow Transplant; 2007 Sep; 13(9):1073-82. PubMed ID: 17697970
[TBL] [Abstract][Full Text] [Related]
26. Outcomes of unrelated cord blood transplantation in pediatric recipients.
Styczynski J; Cheung YK; Garvin J; Savage DG; Billote GB; Harrison L; Skerrett D; Wolownik K; Wischhover C; Hawks R; Bradley MB; Del Toro G; George D; Yamashiro D; van de Ven C; Cairo MS
Bone Marrow Transplant; 2004 Jul; 34(2):129-36. PubMed ID: 15107815
[TBL] [Abstract][Full Text] [Related]
27. Hematopoietic engraftment in recipients of unrelated donor umbilical cord blood is affected by the CD34+ and CD8+ cell doses.
Terakura S; Azuma E; Murata M; Kumamoto T; Hirayama M; Atsuta Y; Kodera Y; Yazaki M; Naoe T; Kato K
Biol Blood Marrow Transplant; 2007 Jul; 13(7):822-30. PubMed ID: 17580260
[TBL] [Abstract][Full Text] [Related]
28. Allogeneic peripheral blood stem cell transplantation from two- or three-loci-mismatched related donors in adult Japanese patients with high-risk hematologic malignancies.
Yamasaki S; Ohno Y; Taniguchi S; Yoshida T; Hayashi S; Ogawa H; Shimazaki C; Takahashi S; Kasai M; Wake A; Nishimura M; Tokunaga K; Gondo H; Takaue Y; Harada M; Mineishi S;
Bone Marrow Transplant; 2004 Feb; 33(3):279-89. PubMed ID: 14647250
[TBL] [Abstract][Full Text] [Related]
29. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449
[TBL] [Abstract][Full Text] [Related]
30. Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases.
Bradley MB; Satwani P; Baldinger L; Morris E; van de Ven C; Del Toro G; Garvin J; George D; Bhatia M; Roman E; Baxter-Lowe LA; Schwartz J; Qualter E; Hawks R; Wolownik K; Foley S; Militano O; Leclere J; Cheung YK; Cairo MS
Bone Marrow Transplant; 2007 Oct; 40(7):621-31. PubMed ID: 17660841
[TBL] [Abstract][Full Text] [Related]
31. Umbilical cord blood transplant for adult patients with severe aplastic anemia using anti-lymphocyte globulin and cyclophosphamide as conditioning therapy.
Mao P; Wang S; Wang S; Zhu Z; Liv Q; Xuv Y; Mo W; Ying Y
Bone Marrow Transplant; 2004 Jan; 33(1):33-8. PubMed ID: 14704655
[TBL] [Abstract][Full Text] [Related]
32. Risk factor analysis of outcomes after unrelated cord blood transplantation in patients with hurler syndrome.
Boelens JJ; Rocha V; Aldenhoven M; Wynn R; O'Meara A; Michel G; Ionescu I; Parikh S; Prasad VK; Szabolcs P; Escolar M; Gluckman E; Cavazzana-Calvo M; Kurtzberg J;
Biol Blood Marrow Transplant; 2009 May; 15(5):618-25. PubMed ID: 19361754
[TBL] [Abstract][Full Text] [Related]
33. Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications.
Majhail NS; Mothukuri JM; Brunstein CG; Weisdorf DJ
Biol Blood Marrow Transplant; 2009 May; 15(5):564-73. PubMed ID: 19361748
[TBL] [Abstract][Full Text] [Related]
34. [Umbilical cord blood as a source of stem cells].
Bojanić I; Golubić Cepulić B
Acta Med Croatica; 2006 Jun; 60(3):215-25. PubMed ID: 16933834
[TBL] [Abstract][Full Text] [Related]
35. [Unrelated umbilical cord blood transplantation as a treatment for children with malignant leukemia].
Tang XF; Luan Z; Xu SX; Wu NH; Huang YZ; Wang K
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):5-8. PubMed ID: 18289460
[TBL] [Abstract][Full Text] [Related]
36. Features of EBV reactivation after reduced intensity conditioning unrelated umbilical cord blood transplantation.
Peric Z; Cahu X; Chevallier P; Brissot E; Malard F; Guillaume T; Delaunay J; Ayari S; Dubruille V; Le Gouill S; Mahé B; Gastinne T; Blin N; Saulquin B; Harousseau JL; Moreau P; Coste-Burel M; Imbert-Marcille BM; Mohty M
Bone Marrow Transplant; 2012 Feb; 47(2):251-7. PubMed ID: 21441959
[TBL] [Abstract][Full Text] [Related]
37. Disseminated tuberculosis following reduced-intensity cord blood transplantation for adult patients with hematological diseases.
Maeda T; Kusumi E; Kami M; Kawabata M; Le Pavoux A; Hara S; Chizuka A; Murashige N; Tanimoto TE; Matsumura T; Yuji K; Wake A; Miyakoshi S; Morinaga S; Taniguchi S;
Bone Marrow Transplant; 2005 Jan; 35(1):91-7. PubMed ID: 15516933
[TBL] [Abstract][Full Text] [Related]
38. Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I-II clinical trial.
Macmillan ML; Blazar BR; DeFor TE; Wagner JE
Bone Marrow Transplant; 2009 Mar; 43(6):447-54. PubMed ID: 18955980
[TBL] [Abstract][Full Text] [Related]
39. Unrelated umbilical cord blood transplantation using a TBI/FLAG conditioning regimen for adults with hematologic malignancies.
Okada M; Fujimori Y; Misawa M; Kai S; Nakajima T; Okikawa Y; Satake A; Itoi H; Takatsuka H; Itsukuma T; Nishioka K; Tamaki H; Ikegame K; Hara H; Ogawa H
Biol Blood Marrow Transplant; 2008 Aug; 14(8):896-903. PubMed ID: 18640573
[TBL] [Abstract][Full Text] [Related]
40. Analysis of hematopoietic cell transplants using plasma-depleted cord blood products that are not red blood cell reduced.
Chow R; Nademanee A; Rosenthal J; Karanes C; Jaing TH; Graham ML; Tsukahara E; Wang B; Gjertson D; Tan P; Forman S; Petz LD
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1346-57. PubMed ID: 17950921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]